Bibliography
- DRESSMAN JB, AMIDON GL, FLEISHER D: Absorption potential: estimating the fraction absorbed for orally administered compounds. J. Pharm. Sci. (1985) 74:588–589.
- BALON K, MUELLER BW, RIEBESEHL BU: Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res. (1999) 16:882–888.
- AMIDON GL, LENNERNÄS H, SHAH VP, CRISON JR: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. (1995) 12:413–420.
- FDA: Guidance for Industry, Waiver of In vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. FDA, Washington, DC, USA (2000).
- RINAKI E, VALSAMI G, MACHERAS P: Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharm. Res. (2003) 20:1917–1925.
- BERGSTRÖM CAS, STRAFFORD M, LAZAROVA L, AVDEEF A, LUTHMAN K, ARTURSSON P: Absorption classification of oral drugs based on molecular surface properties. J. Med. Chem. (2003) 46:558–570.
- JOHNSON K, SWINDELL A: Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharm. Res. (1996) 13:1795–1798.
- CURATOLO W: Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. Pharm. Sci. Tech. Today (1998) 1:387–393.
- AVDEEF A: Absorption and Drug Development. Wiley-Intercience, New York, USA (2003):116–246.
- KARLSSON J, ARTURSSON P: A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int. J. Pharm. (1991) 71:55–64.
- ADSON A, BURTON PS, RAUB TJ, BARSUHN CL, AUDUS KL, HO NFH: Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J. Pharm. Sci. (1995) 84:1197–1204.
- ARTURSSON P: Application of physicochemical properties of molecules to predict intestinal permeability. AAPS Workshop on Permeability Definitions and Regulatory Standards. Arlington, VA, USA (1998).
- YAMASHITA S, FURUBAYASHI T, KATAOKA M, SAKANE T, SEZAKI H, TOKUDA H: Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. (2000) 10:195–204.
- HO NFH, RAUB TJ, BURTON PS et al.: Quantitative approaches to delineate passive transport mechanisms in cell culture monolayers. In: Transport Processes in Pharmaceutical Systems. GL Amidon, PI Lee, EM Topp (Eds). Marcel Dekker, New York, USA (2000):219–316.
- KANSY M, SENNER F, GUBERNATOR K: Physicochemical high throughput screening: parallel artificial membrane permeability assay in the description of passive absorption processes. J. Med. Chem. (1998) 41:1007–1010.
- AVDEEF A, ARTURSSON P, NEUHOFF S, LAZAROVA L, GRÅSJÖ J, TAVELIN S: Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pKa flux method. Eur. J. Pharm. Sci. (2005) (in press).
- AVDEEF A, STRAFFORD M, BLOCK E, BALOGH MP, CHAMBLISS W, KHAN I: Drug absorption in vitro model: filterimmobilized artificial membranes. 2. Studies of the permeability properties of lactones in piper methysticum forst. Eur. J. Pharm. Sci. (2001) 14:271–280.
- KANSY M, FISCHER H, KRATZAT K, SENNER F, WAGNER B, PARRILLA I: High-throughput aritificial membrane permeability studies in early lead discovery and development. In: Pharmacokinetic Optimization in Drug Research. B Testa, H van de Waterbeemd, G Folkers, R Guy (Eds), Verlag Helvetica Chimica Acta, Zürich and Wiley - VCH, Weinheim, Germany (2001):447–464.
- AVDEEF A: High-throughput measurements of solubility profiles. In: Pharmacokinetic Optimization in Drug Research. B Testa, H van de Waterbeemd, G Folkers, R Guy (Eds), Verlag Helvetica Chimica Acta,Zürich and Wiley - VCH, Weinheim, Germany (2001):305–326.
- FALLER B, WOHNSLAND F: Physicochemical parameters as tools in drug discovery and lead optimization. In: Pharmacokinetic Optimization in Drug Research. B Testa, H van de Waterbeemd, G Folkers, R Guy (Eds), Verlag Helvetica Chimica Acta, Zürich and Wiley - VCH, Weinheim, Germany (2001):257–274.
- SUGANO K, HAMADA H, MACHIDA M, USHIO H, SAITOH K, TERADA K: Optimized conditions of biomimetic artificial membrane permeability assay. Int. J. Pharm. (2001) 228:181–188.
- SUGANO K, HAMADA H, MACHIDA M, USHIO H: High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeability assay. J. Biomolec. Screen. (2001) 6:189–196.
- WOHNSLAND F, FALLER B: Highthroughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. J. Med. Chem. (2001) 44:923–930.
- SUGANO K, TAKATA N, MACHIDA M, SAITOH K, TERADA K: Prediction of passive intestinal absorption using biomimetic artificial membrane permeation assay and the paracellular pathway model. Int. J. Pharm. (2002) 241:241–251.
- ZHU C, JIANG L, CHEN T-M, HWANG K-K: A comparative study of artificial membrane permeability assay for high-throughput profiling of drug absorption potential. Eur. J. Med. Chem. (2002) 37:399–407.
- VEBER DF, JOHNSON SR, CHENG H-Y, SMITH BR, WARD KW, KOPPLE KD: Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. (2002) 45:2615–2623.
- LEVIN JI, DU TM: Sulfonate ester hydroxamic acids as potent and selective inhibitors of TACE enzyme. Drug Des. Discov. (2003) 18:123–126.
- DI L, KERNS EH, FAN K, MCCONNELL OJ, CARTER GT: High throughput artificial membrane permeability assay for blood-brain barrier. Eur. J. Med. Chem. (2003) 38 223–232.
- SUGANO K, NABUCHI Y, MACHIDA M, ASO Y: Prediction of human intestinal permeability using artificial membrane permeability. Int. J. Pharm. (2003) 257:245–251.
- HWANG KK, MARTIN NE, JIANG L, ZHU C: Permeation prediction of M100240 using the parallel artificial membrane permeability assay. J. Pharm. Pharmaceut. Sci. (2003) 6:315–320.
- RUELL JA, TSINMAN KL, AVDEEF A: PAMPA - a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKaflux — optimized design (pOD-PAMPA). Eur. J. Pharm. Sci. (2003) 20:393–402.
- LIU H, SABUS C, CARTER GT, DU C, AVDEEF A, TISCHLER M: Solubilizer selection in the parallel artificial membrane permeability assay (PAMPA) for in vitro permeability measurement of low solubility compounds. Pharm. Res. (2003) 20:1820–1826.
- NIELSEN P, AVDEEF A: PAMPA - a drug absorption in vitro model. 8. Apparent filter porosity and the unstirred water layer. Eur. J. Pharm. Sci. (2004) 22:33–41.
- OBATA K, SUGANO K, MACHIDA M, ASO Y: Biopharmaceuitics classification by high throughput solubility assay and PAMPA. Drug Dev. Ind. Pharm. (2004) 30:181–185.
- HUQUE FTT, BOX K, PLATTS JA, COMER J: Permeability through DOPC/ dodecane membranes: measurement and LFER modelling. Eur. J. Pharm. Sci. (2004) 23:223–232.
- ANO R, KIMURA Y, SHIMA M, MATSUNO R, UENO T, AKAMATSU M: Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorg. Med. Chem. (2004) 12:257–264.
- AVDEEF A, NIELSEN PE, TSINMAN O: PAMPA - a drug absorption in vitro model. 11. Matching the in vivo unstirred water layer thickness by individual-well stirring in microtitre plates. Eur. J. Pharm. Sci. (2004) 22:365–374.
- BERMEJO M, AVDEEF A, RUIZ A et al.: PAMPA - a drug absorption in vitro model. 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur. J. Pharm. Sci. (2004) 21:429–441.
- RUELL JA, TSINMAN O, AVDEEF A: Acid-base cosolvent method for determining aqueous permeability of amiodarone, itraconazole, tamoxifen, terfenadine and other very insoluble molecules. Chem. Pharm. Bull. (2004) 52:561–565.
- MIRET S, ABRAHAMS L, DE GOENE EM: Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. J. Biomed. Screen. (2004) 9:598–606.
- SAITOH R, SUGANO K, TAKATA N et al.: Correction of permeability with pore radius of tight junctions in Caco-2 monolayers improves the prediction of the dose fraction of hydrophilic drugs absorbed in humans. Pharm. Res. (2004) 21:749–755.
- KERNS EH, DI L, PETUSKY S, FARRIS M, LEY R, JUPP P: Combined application of parallel membrane permeability assay and Caco-2 permeability assays in drug discovery. J. Pharm. Sci. (2004) 93:1440–1453.
- CARON G, ERMONDI G, DAMIANO A et al.: Ionization, lipophilicity, and molecular modeling to investigate permeability and other biological properties of amlodipine. Bioorg. Med. Chem. (2004) 23:6107–6118.
- ABDICHE YN, MYSZKA DG: Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal. Biochem. (2004) 328:233–243.
- NAGAHARA N, TAVELIN S, ARTURSSON P: The contribution of the paracellular route to pH dependent permeability of ionizable drugs. J. Pharm Sci. (2004) 93:2972–2984.
- MATSSON P, BERGSTRÖM CA, NAGAHARA N, TAVELIN S, NORINDER U, ARTURSSON P: Exploring the role of different drug transport routes in permeability screening. J. Med. Chem. (2005) (in press).
- AVDEEF A, TSINMAN O: PAMPA - a drug absorption in vitro model. 13. Chemical selectivity due to membrane hydrogen bonding: in combo comparisons of HDM-, DOPC- and DS-PAMPA models. Eur. J. Pharm. Sci. (2005) submitted.
- AVDEEF A: Physicochemical profiling (solubility, permeability, and charge state). Curr. Topics Med. Chem. (2001) 1:277–351.
- KERNS EH: High throughput physicochemical profiling for drug discovery. J. Pharm. Sci. (2001) 90:1838–1858.
- LIPINSKI CA: Observation on current ADMET technology: no uniformity exists. Annual Meeting of the Society of Biomolecular Screening. The Hauge, The Netherlands (2002).
- KERNS EH, DI L: Multivariate pharmaceutical profiling for drug discovery. Curr. Top. Med. Chem. (2002) 2:87–98.
- KARIV I, ROURICK RA, KASSEL DB, CHUNG TD: Improvement of ‘hit-to-lead’ optimization by integration of in vitro HTS experimental models for early determination of pharmacokinetic properties. Comb. Chem. High Throughput Screen. (2002) 5:459–472.
- AVDEEF A: High-throughput measurements of permeability profiles. In: Drug Bioavailability. Estimation of Solubility, Permeability, Absorption and Bioavailability. H van de Waterbeemd, H Lennernäs, P Artursson (Eds). Wiley - VCH: Weinheim, Germany (2003):46–70.
- RUELL J: Membrane-based drug assays. Mod. Drug Disc. (2003):28–30.
- KERNS EH, DI L: Pharmaceutical profiling in drug discovery. Drug Disc. Today (2003) 8:316–323.
- DI L, KERNS EH: Profiling drug-like properties in discovery research. Curr. Opin. Chem. Biol. (2003) 7:402–408.
- YOUDIM KA, AVDEEF A, ABBOTT NJ: In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Disc. Today (2003) 8:997–1003.
- AVDEEF A, TESTA B: Physicochemical profiling in drug research: a brief state-ofthe- art of experimental techniques. Cell. Molec. Life Sci. (2003) 59:1681–1689.
- RUELL JA, AVDEEF A: Absorption using the PAMPA Approach. In: Optimization in Drug Discovery: In vitro Methods. Z Yan, GW Caldwell (Eds), The Humana Press, Totowa, NJ, USA (2004):37–64.
- KANSY M, FISCHER H, BENDELS S et al.: Physicochemical methods for estimating permeability and related properties. In: Pharmaceutical Profiling in Drug Discovery for Lead Selection. RT Borchardt, EH Kerns, CA Lipinski, DR Thakker, B Wang (Eds), AAPS Press, Arlington, VA, USA (2004):197–216.
- FALLER B: High-throughput physicochemical profiling: potential and limitations. In: Analysis and Purification Methods in Combinatorial Chemistry. Wiley ’ Sons, Inc, New York, USA (2004) (in press).
- KANSY M, AVDEEF A, FISCHER H: Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists. Drug Discov. Today: Technologies (2005) (in press).
- AVDEEF A: HT solubility and permeability: MAD-PAMPA analysis. In: Physicochemical and Biological Profiling in Drug Research. SD Krämer, G Folkers, B Testa (Eds), Wiley-VCH, Weinheim, Germany (2005) (in press).
- RUELL J, AVDEEF A: A meaured solution. Mod. Drug Disc. (2003):47–49.
- PARTRIDGE WM: Peptide Drug Delivery to the Brain. Raven Press, New York, USA (1991):52–88.
- GUTKNECHT J, TOSTESON DC: Diffusion of weak acids across lipid membranes: effects of chemical reactions in the unstirred layers. Science (1973) 182:1258–1261.
- WALTER A, GUTKNECHT J: Monocarboxylic acid permeation through lipid bilayer membranes. J. Mem. Biol. (1984) 77:255–264.
- ANTONENKO YN, DENISOV GA, POHL P: Weak acid transport across bilayer lipid membrane in the presence of buffers. Biophys. J. (1993) 64:1701–1710.
- XIANG T-X, ANDERSON BD: Diffusion of ionizable solutes across planar lipid bilayer membranes: boundary-layer pH gradients and the effect of buffers. Pharm. Res. (1993) 10:1654–1661.
- LENNERNÄS H: Human intestinal permeability. J. Pharm. Sci. (1998) 87:403–410.
- VAN DE WATERBEEMD H: Propertybased optimization. In: Physicochemical and Biological Profiling in Drug Research. SD Krämer, G Folkers, B Testa (Eds), Wiley-VCH, Weinheim, Germany (2005) (in press).
- ABRAHAM M H: Scales of hydrogen bonding - their construction and application to physicochemical and biochemical processes. Chem. Soc. Revs. (1993) 22:73–83.
- ABRAHAM MH, IBRAHIM A, ZISSIMOS AM, ZHAO YH, COMER J, REYNOLDS DP: Application of hydrogen bonding calculations in property based drug design. Drug Disc. Today (2002) 7:1056–1063.
- JAPERTAS P, DIDZIAPETRIS R, PETRAUSKAS A: Fragmental methods in the design of new compounds. Applications of the advanced algorithm builder. Quant. Struct. Activ. Relat. (2002) 21:23–37.
- ZMUIDINAVICIUS D, DIDZIAPETRIS R, JAPERTAS P, AVDEEF A, PETRAUSKAS A: Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption. J. Pharm. Sci. (2003) 92:621–633.
- DIDZIAPETRIS R, JAPERTAS P, AVDEEF A, PETRAUSKAS A: Classification analysis of P-glycoprotein substrate specificity. J. Drug Target. (2003) 11:391–406.
- AVDEEF A: Assessment of distribution - pH profiles. In: Methods and Principles in Medicinal Chemistry, Vol.4. V Pliska, B Testa, H van de Waterbeemd (Eds). VCH Publishers, Weinheim, Germany (1996):109–139.